MedTrace Logo

Uterotonics for Severe Preeclampsia

NCT04756661 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2021-02-16

No results posted yet for this study

Summary

The study compares the effect of Intravenous carbetocin versus combined use of intravenous oxytocin and rectal misoprostol for prevention of postpartum hemorrhage during delivery of women with severe preeclampsia

Conditions

  • Preeclampsia Severe

Interventions

DRUG

Carbetocin

100 mcg of Carbetocin intravenous injection

DRUG

Oxytocin

10 IU oxytocin IV drip

DRUG

Misoprostol

400 mcg rectal

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-31
Completion
2021-02-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756661 on ClinicalTrials.gov